» Articles » PMID: 9013300

Clinical Utility of Adjuvant Growth Hormone in the Treatment of Patients with Polycystic Ovaries Undergoing in Vitro Fertilization

Overview
Publisher Springer
Date 1997 Jan 1
PMID 9013300
Authors
Affiliations
Soon will be listed here.
References
1.
Adashi E, Resnick C, DErcole A, Svoboda M, Van Wyk J . Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev. 1985; 6(3):400-20. DOI: 10.1210/edrv-6-3-400. View

2.
Barreca A, Del Monte P, Ponzani P, Artini P, Genazzani A, Minuto F . Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome. Fertil Steril. 1996; 65(4):739-45. DOI: 10.1016/s0015-0282(16)58206-5. View

3.
Jia X, Kalmijn J, Hsueh A . Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology. 1986; 118(4):1401-9. DOI: 10.1210/endo-118-4-1401. View

4.
Ramasharma K, Cabrera C, Li C . Identification of insulin-like growth factor-II in human seminal and follicular fluids. Biochem Biophys Res Commun. 1986; 140(2):536-42. DOI: 10.1016/0006-291x(86)90765-5. View

5.
Franks S, Mason H, Polson D, Winston R, Margara R, Reed M . Mechanism and management of ovulatory failure in women with polycystic ovary syndrome. Hum Reprod. 1988; 3(4):531-4. DOI: 10.1093/oxfordjournals.humrep.a136739. View